Looking to log more miles? No matter what “running longer” means for you, we bet it’s a goal you think about often—and with our latest program, it’s finally within reach. In How to Run Longer, we’ll ...

The bidding process was questioned on Friday after the company, Public Partnerships LLC, admitted it had exchanged unspecified communications with state officials before the contract was awarded. By ...

The Minneapolis City Council is reallocating the funds originally designated for a church and nonprofit run by a north Minneapolis pastor who is facing criticism for past statements he’s made. Members ...

SOUTH BEND, Ind. (WNDU) - A Notre Dame track and field athlete is starting something new this fall. Sophomore Landon Stormer is partnering with the national organization Run Your City to bring it to ...

Girls on the Run Rhode Island empowers girls with life skills through a curriculum that integrates running. The organization measures success by participant feedback, program completion, and observed ...

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...

Not using LSP and don't have clangd on my Linux system, I've been getting random 'Cannot run program "clangd"' popups since I upgraded to 2025-06; once it happened when I was starting a debugger, ...

There’s no doubt that in college football, running back can be a pivotal position for teams looking to make a national championship run, and many programs have loaded up on talent. Of course, having ...

NORTH KANSAS CITY, Mo. (KCTV) - Harvesters Kansas City confirmed they’re having to reduce some feeding programs, limiting options. However, the food community network said it is working to make the ...

BYU running back Pokaiaua Haunga has been dismissed from the program, according to reports. The redshirt freshman rusher was no longer on the roster during the start of fall camp. BYU offensive ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...